Mair Therapeutics, a Nijmegen, the Netherlands-based biotechnology startup growing remedies for neurodegenerative problems, raised an undisclosed quantity in Pre-Seed funding.
The spherical was led by Torrey Pines Funding.
The corporate intends to make use of the funds to increase operations an its developement efforts.
Mair Therapeutics is devoted to discovering compounds that regulate the lysosomal ion channel TMEM175, which controls lysosomal pH to take care of optimum circumstances for degrading protein aggregates – hallmarks of Parkinson’s illness.
FinSMEs
14/02/2025
